Literature DB >> 6783066

Synthesis and release of factor VIII by cultured human endothelial cells.

E G Tuddenham, J Lazarchick, L W Hoyer.   

Abstract

Endothelial cells (ECs) derived from human umbilical veins were cultured in order to study the physiological control of factor VIII synthesis and release. The culture media were studied from multiple replicate cultures at confluence. Factor VIII related antigen (VIIIR:Ag) and factor VIII coagulant antigen (VIII:CAg) were measured by sensitive immunoradiometric assays. De novo synthesis of factor VIII related protein (VIII:R) was quantitated by incorporation of labelled amino acids into specific protein subunits. The following agents were added to the culture medium in a range of concentrations from physiological to pharmacological: adrenaline, 5 hydroxytryptamine, 2,3-DPG, cyclic AMP, thyroxine, hydrocortisone, and human growth hormone. None of them had any effect at any concentration on the rate of accumulation of VIIIR:Ag in the culture medium. Addition of exogenous factor VIII had no effect on do novo synthesis of VIII:R. VIII:CAg was found to be stable under the conditions of culture but none was released from the ECs. Long-term monocyte cultures also failed to release VIII:CAg. It appears that VIII:R is a constitutive gene product of umbilical vein endothelial cells and that VIII:CAg is not made by these cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6783066     DOI: 10.1111/j.1365-2141.1981.tb02691.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

1.  The effects of desmopressin on hemostatic parameters in the normal dog.

Authors:  I B Johnstone; S Crane
Journal:  Can J Vet Res       Date:  1986-04       Impact factor: 1.310

2.  [Significance of the endothelium of the vascular wall for maintaining hemostasis].

Authors:  U Delvos; G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1985-12-16

3.  Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.

Authors:  E J Bowie; L A Solberg; D N Fass; C M Johnson; G J Knutson; M L Stewart; L J Zoecklein
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Factor VIII related antigen in the assessment of vasculitis.

Authors:  A D Woolf; G Wakerley; T B Wallington; D G Scott; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

5.  The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.

Authors:  I B Johnstone; S Crane
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

6.  The ultrastructural localization of von Willebrand factor in endothelial cells.

Authors:  M J Warhol; J M Sweet
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

7.  Von Willebrand factor antigen in assessment of vasculitis in patients with connective tissue diseases.

Authors:  J Kloczko; A Kuryliszyn-Moskal; K Bernacka; M Bielawiec; B Cylwik; P Radziwon
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

8.  Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells.

Authors:  J Gebrane-Younès; E M Cramer; L Orcel; J P Caen
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.

Authors:  C S Lau; M McLaren; J Hanslip; M Kerr; J J Belch
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

10.  Regulation of human megakaryocytopoiesis. An in vito analysis.

Authors:  E M Mazur; R Hoffman; E Bruno
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.